北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 中国药物依赖性研究所  > 期刊论文
学科主题: 药物依赖
题名:
Sustained-Release Bupropion for Smoking Cessation in a Chinese Sample: A Double-Blind, Placebo-Controlled, Randomized Trial
作者: Sheng, Li-xia1,2,3; Tang, Yi-lang4; Jiang, Zuo-ning2; Yao, Chong-hua5; Gao, Jun-yu6; Xu, Guo-Zhu7; Tong, Xin-yuan8
刊名: NICOTINE & TOBACCO RESEARCH
发表日期: 2013-02-01
DOI: 10.1093/ntr/nts124
卷: 15, 期:2, 页:320-325
收录类别: SCI ; SSCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Substance Abuse ; Public, Environmental & Occupational Health
研究领域[WOS]: Substance Abuse ; Public, Environmental & Occupational Health
关键词[WOS]: CLINICAL-TRIAL ; SMOKERS ; DEPRESSION ; PREVALENCE ; PREDICTORS ; REDUCTION
英文摘要:

Bupropion is a first-line pharmacological aid for smoking cessation; however, no clinical trials have been conducted in a Chinese population.

We enrolled 248 smokers in a hospital-based, randomized, smoking cessation trial conducted at four outpatient centers in Beijing. A total of 123 participants received an 8-week course of sustained-release bupropion (Bup-SR) and 125 participants received 8 weeks of placebo. All participants received brief education and counseling on smoking cessation. We determined rates of abstinence and smoking reduction based on chemical verification and self-report at 8 and 12 weeks.

At the end of the medication treatment (8 weeks) and at the end of the trial (12 weeks), the abstinence rates for Bup-SR were 29.3% and 39.8%, respectively, and 10.4% and 8.0% for placebo, respectively (both p < .001). Bup-SR was also superior to placebo in reducing cigarettes per day and urinary cotinine levels.

Bup-SR is efficacious for smoking cessation in healthy Chinese patients treated in the outpatient setting. It is well tolerated with a few mild side effects.

语种: 英语
项目资助者: Zhejiang Jinxin Pharmaceutical Co, Ltd.
WOS记录号: WOS:000313826600002
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/58686
Appears in Collections:中国药物依赖性研究所_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Capital Med Univ, Beijing Anding Hosp, Dept Med Affairs, Beijing 100088, Peoples R China
2.Natl Drug Dependence Treatment Ctr, Beijing, Peoples R China
3.Natl Ctr Clin Trials Psychotrop Drugs, Beijing, Peoples R China
4.Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA
5.PLA Med Coll Continuat Educ, Dept Med Stat, Beijing, Peoples R China
6.Capital Med Univ, Beijing Anzhen Hosp, Beijing 100088, Peoples R China
7.Acad Mil Med Sci, Affiliated Hosp, Beijing, Peoples R China
8.Peking Univ, Hlth Sci Ctr, Natl Inst Drug Dependence, Beijing 100871, Peoples R China

Recommended Citation:
Sheng, Li-xia,Tang, Yi-lang,Jiang, Zuo-ning,et al. Sustained-Release Bupropion for Smoking Cessation in a Chinese Sample: A Double-Blind, Placebo-Controlled, Randomized Trial[J]. NICOTINE &amp; TOBACCO RESEARCH,2013,15(2):320-325.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Sheng, Li-xia]'s Articles
[Tang, Yi-lang]'s Articles
[Jiang, Zuo-ning]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Sheng, Li-xia]‘s Articles
[Tang, Yi-lang]‘s Articles
[Jiang, Zuo-ning]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace